Statizoid

Health in High income (World Bank)

155 indicators covering health for High income (World Bank).

IndicatorLatest Year10-yr change Rank
ex - expectation of life at age x 79.65 2021 down 0.4% 1st
ndx - number of people dying between ages x and x+n 423.77 2021 down 16.6% 11th
Cases started on MDR-TB treatment 25,231 2024 up 3.1% 7th
Raised fasting blood glucose (>=7.0 mmol/L) 6.9 2014 up 7.8% 11th
Raised fasting blood glucose (>= 7.0 mmol/L) 8.9 2014 up 15.6% 4th
Percentage of total deaths due to NCDs overall and percentage of 6.18 2019 down 0.4% 9th
Low birth weight prevalence 8.0% 2020 up 1.3% 12th
Inactivated first-dose polio vaccine (IPV1) immunization coverage 97.0% 2025 up 2.1% 1st
Low birth weight number 1,078 2020 down 11.1% 12th
Concentrations of fine particulate matter 9.83 2023 down 23.5% 13th
New or unknown treatment history cases: Pulmonary, bacteriologically 71,347 2023 down 40.5% 10th
Number of children aged 6-59 months with anaemia 8,785 2019 up 5.5% 11th
Prevalence of anaemia in children aged 6-59 months 13.5% 2019 up 9.8% 11th
Number of deaths attributed to non-communicable diseases, by type of 2.72 million 2019 up 8.6% 4th
HIV-positive TB patients on ART (antiretroviral therapy) 81.0% 2024 up 19.1% 8th
Treatment success rate for patients treated for MDR-TB 65.0% 2022 up 54.8% 10th
Treatment success rate: HIV-positive TB cases 54 2023 down 8.5% 11th
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 94.0% 2025 — 1st
Number of prevalent tuberculosis cases 360,000 2014 down 36.8% 10th
Japanese encephalitis - number of reported cases 21 2025 down 57.1% 6th
Neonates protected at birth against neonatal tetanus (PAB) 99.0% 2022 up 5.3% 1st
HPV immunization coverage estimates among primary target cohort (9-14) 60.0% 2025 up 46.3% 2nd
Tuberculosis - new and relapse cases 124,093 2011 down 24.9% 11th
Total number of notified TB cases 285,290 2014 down 15.9% 10th
Underweight numbers among children under 5 years of age (millions) 537.6 2024 down 24.6% 12th
Underweight prevalence among children under 5 years of age (%) 0.8% 2024 down 11.1% 12th
Smear-positive tuberculosis treatment-success rate 63.0% 2011 down 11.3% 10th
Insufficiently active 79.4 2016 down 1.2% 9th
Yellow fever vaccine (YFV) immunization coverage among 1-year olds 33.0% 2025 unchanged 8th
Preterm birth rate 8.37 2020 up 2.8% 12th
Preterm birth 994,023 2020 down 8.3% 12th
Treatment success rate: XDR-TB cases 53 2022 up 96.3% 11th
Confirmed cases of MDR-TB 15,948 2012 up 1,224.6% 7th
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) 38.0% 2014 down 53.1% 11th
Confirmed cases of MDR-TB started treatment for MDR-TB 130.0% 2012 — 1st